4//SEC Filing
Taylor Ben R 4
Accession 0001601830-24-000249
CIK 0001601830other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:16 PM ET
Size
11.8 KB
Accession
0001601830-24-000249
Insider Transaction Report
Form 4
Taylor Ben R
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-12-19+370,343→ 844,210 total - Award
Stock Option (Right to Buy)
2024-12-19+740,686→ 740,686 totalExercise: $6.09Exp: 2034-12-18→ Class A Common Stock (740,686 underlying)
Holdings
- 289,837
Stock Option (Right to Buy)
Exercise: $0.04Exp: 2030-11-26→ Class A Common Stock (0 underlying) - 81,154
Stock Option (Right to Buy)
Exercise: $0.14Exp: 2031-07-01→ Class A Common Stock (0 underlying) - 92,748
Stock Option (Right to Buy)
Exercise: $0.06Exp: 2031-04-02→ Class A Common Stock (0 underlying)
Footnotes (5)
- [F1]These shares represent an award of restricted stock units which vest as to 1/16th of the shares subject to the award quarterly, beginning February 15, 2025, subject to the Mr. Taylor's continued service through each vesting date.
- [F2]1/48th of the shares subject to the award vests and become exercisable on January 2, 2025, and each month thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F3]Twenty-five percent of the shares subject to the award vest and become exercisable on November 17, 2021, and the remaining shares subject to the award vest and become exercisable in annual installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F4]Twenty-five percent of the shares subject to the award vest and become exercisable on April 3, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F5]Twenty-five percent of the shares subject to the award vest and become exercisable on July 1, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001712276
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:16 PM ET
- Size
- 11.8 KB